Free Trial
→ Before you buy SpaceX shares, consider this alternative approach (From Weiss Ratings) (Ad)tc pixel Free CNSP Stock Alerts

CNS Pharmaceuticals (CNSP) Short Interest Ratio & Short Volume

CNS Pharmaceuticals logo
$5.14 -0.38 (-6.79%)
As of 09:54 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

CNS Pharmaceuticals Short Interest Overview

As of April 30, 2026, CNS Pharmaceuticals (CNSP) had a short interest of 38,968 shares sold short, representing 4.80% of the public float. This marks a -33.18% decrease in short interest since the prior report. The short interest ratio (days to cover) is 2.1, meaning it would take 2.1 days of the average trading volume of 977,771 shares to cover all short positions.

Current Short Interest
38,968 shares
Previous Short Interest
58,320 shares
Change Vs. Previous Month
-33.18%
Dollar Volume Sold Short
$88.46 thousand
Short Interest Ratio
2.1 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
810,000 shares
Short Percent of Float
4.80%
Today's Trading Volume
7,027 shares
Average Trading Volume
977,771 shares
Today's Volume Vs. Average
1%
Short Selling CNS Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for CNS Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CNSP Short Interest Over Time

CNSP Days to Cover Over Time

CNSP Percentage of Float Shorted Over Time

CNS Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202638,968 shares $88.46 thousand -33.2%4.8%2.1 $2.27
4/15/202658,320 shares $160.38 thousand +8.0%7.2%1.89 $2.75
3/31/202654,014 shares $129.09 thousand +44.5%6.7%1.25 $2.39
3/13/202637,380 shares $91.21 thousand -13.9%6.0%0.74 $2.44
2/27/202643,399 shares $134.97 thousand +5.0%7.0%3.07 $3.11
2/13/202641,351 shares $143.07 thousand +35.8%6.7%1.62 $3.46
1/30/202630,452 shares $169.92 thousand +7.5%4.9%0.97 $5.58
1/15/202628,320 shares $208.72 thousand +1.1%4.6%0.25 $7.37
12/31/202528,011 shares $147.06 thousand +9.4%4.5%1.08 $5.25
12/15/202525,600 shares $181.50 thousand +47.2%4.1%1.91 $7.09
11/28/202517,390 shares $123.28 thousand -53.1%2.8%2.6 $7.09
11/14/202537,078 shares $255.84 thousand +109.5%6.0%1.77 $6.90
10/31/202517,700 shares $136.29 thousand -61.3%3.1%1.23 $7.70
10/15/202545,700 shares $435.06 thousand +9.3%8.0%0.9 $9.52
9/30/202541,800 shares $376.20 thousand -22.3%7.3%0.8 $9.00
9/15/202553,800 shares $494.96 thousand -15.4%9.4%1.1 $9.20
8/31/202563,600 shares $395.59 thousand +65.2%11.1%1.6 $6.22
8/15/202538,500 shares $195.97 thousand -4.9%6.7%0.9 $5.09
7/31/202540,500 shares $323.19 thousand +29.8%7.7%0.3 $7.98
7/15/202531,200 shares $324.31 thousand -92.2%N/A0.2 $10.39
6/30/2025399,200 shares $329.34 thousand -13.4%7.4%0.2 $0.83
6/15/2025461,100 shares $372.25 thousand +153.4%8.5%0.3 $0.81
5/31/2025182,000 shares $190.19 thousand -75.1%3.4%0.1 $1.05
5/15/2025731,700 shares $921.94 thousand +16.2%13.5%0.4 $1.26
4/30/2025629,900 shares $683.44 thousand +94.5%21.6%1.3 $1.09
4/15/2025323,800 shares $309.88 thousand -4.4%11.1%0.6 $0.96
3/31/2025338,700 shares $460.63 thousand +88.1%11.6%0.5 $1.36
3/15/2025180,100 shares $561.91 thousand -32.9%6.2%0.3 $3.12
2/28/2025268,500 shares $652.46 thousand +241.6%9.9%0.5 $2.43
2/15/202578,600 shares $550.20 thousand -97.8%5.2%0.1 $7.00
1/31/20253,630,000 shares $345.21 thousand -19.9%N/A0.2 $0.10
1/15/20254,530,000 shares $498.30 thousand +861.6%N/A0.2 $0.11
12/31/2024471,100 shares $56.72 thousand -64.8%N/A0 $0.12
12/15/20241,340,000 shares $137.89 thousand -35.3%N/A0.1 $0.10
11/30/20242,070,000 shares $231.84 thousand +202.9%N/A0.1 $0.11
11/15/2024683,300 shares $71.81 thousand -40.1%N/A0 $0.11
10/31/20241,140,000 shares $127.22 thousand +2.7%N/A0.1 $0.11
10/15/20241,110,000 shares $137.86 thousand +63.5%N/A0.1 $0.12
9/30/2024679,000 shares $88.61 thousand +86.2%N/A0.1 $0.13
9/15/2024364,600 shares $54.03 thousand +80.1%N/A0.1 $0.15
Iran's New Leader Just Said Something That Should Terrify Every American (Ad)

Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of the world's oil passing through that corridor, crude has already crossed $100 per barrel. History shows gold surged 571% during the 1973 oil crisis and 425% in 1979. Today, the U.S. holds 8,133 tonnes of gold valued on the books at $42.22 per ounce - while gold trades above $5,000. American Alternative Assets has released The Great Gold Reset report detailing what this gap could mean for investors.tc pixel

Claim your free copy of The Great Gold Reset report today
8/31/2024202,500 shares $31.83 thousand +87.7%N/A0 $0.16
8/15/2024107,900 shares $15.21 thousand -90.3%N/A0 $0.14
7/31/20241,110,000 shares $351.65 thousand +314.3%40.1%0.3 $0.32
7/15/2024267,900 shares $316.12 thousand +229.9%9.7%0.2 $1.18
6/30/202481,200 shares $128.30 thousand +29.7%5.8%0.1 $1.58
6/15/202462,600 shares $174.65 thousand +1,465.0%27.3%0.2 $2.79
5/31/20244,000 shares $43.24 thousand -93.6%1.8%0.2 $10.81
5/15/202462,500 shares $12.01 thousand +100.3%0.6%0.2 $0.19
4/30/202431,200 shares $6.55 thousand +35.1%0.3%0.1 $0.21
4/15/202423,100 shares $5.53 thousand -53.8%0.2%0.1 $0.24
3/31/202450,000 shares $18.10 thousand -51.8%0.5%0.1 $0.36
3/15/2024103,800 shares $36.98 thousand +91.5%1.3%0.3 $0.36
2/29/202454,200 shares $15.07 thousand -47.2%0.7%0.1 $0.28
2/15/2024102,600 shares $29.04 thousand -87.2%1.3%0.3 $0.28
1/31/2024802,400 shares $199.00 thousand +317.1%10.2%2.6 $0.25
1/15/2024192,400 shares $179.89 thousand -10.8%3.1%1.6 $0.94
12/31/2023215,700 shares $273.94 thousand +298.0%3.5%2.1 $1.27
12/15/202354,200 shares $93.77 thousand +30.6%0.9%0.5 $1.73
11/30/202341,500 shares $86.32 thousand +75.1%0.8%0.6 $2.08
11/15/202323,700 shares $45.50 thousand -50.3%0.5%0.3 $1.92
10/31/202347,700 shares $98.74 thousand -36.6%1.2%0.3 $2.07
10/15/202375,200 shares $101.52 thousand +22.7%1.8%0.5 $1.35
9/30/202361,300 shares $69.88 thousand -8.5%1.5%0.5 $1.14
9/15/202367,000 shares $100.50 thousand -45.2%1.6%0.4 $1.50
8/31/2023122,300 shares $209.13 thousand +69.6%3.0%0.6 $1.71
8/15/202372,100 shares $123.29 thousand -3.1%1.8%0.2 $1.71
7/31/202374,400 shares $168.14 thousand +11.4%1.8%0.2 $2.26
7/15/202366,800 shares $142.95 thousand -70.0%1.6%0 $2.14
6/30/2023222,600 shares $496.40 thousand +7.2%5.5%0.1 $2.23
6/15/2023207,600 shares $448.42 thousand -9.4%5.1%0.1 $2.16
5/31/2023229,100 shares $421.54 thousand +91.6%5.7%0.1 $1.84
5/15/2023119,600 shares $166.24 thousand -44.6%3.0%0 $1.39
4/30/2023215,800 shares $325.86 thousand +306.4%10.0%0.1 $1.51
4/15/202353,100 shares $124.79 thousand +410.6%3.1%0 $2.35
3/31/202310,400 shares $10.40 thousand -57.6%0.6%0 $1.00
3/15/202324,500 shares $30.38 thousand +49.4%2.3%0.6 $1.24
2/28/202316,400 shares $30.34 thousand +62.4%1.6%0.4 $1.85
2/15/202310,100 shares $17.37 thousand +206.1%1.0%0.3 $1.72
1/31/20233,300 shares $7.29 thousand +153.9%0.3%0.1 $2.21
1/15/20231,300 shares $3.12 thousand -63.9%0.1%0.1 $2.40
12/30/20223,600 shares $8.64 thousand -65.4%0.3%0.2 $2.40
12/15/202210,400 shares $26.52 thousand -2.8%0.8%0.6 $2.55
11/30/202210,700 shares $32.42 thousand -88.5%1.1%0.7 $3.03
11/15/202293,200 shares $17.72 thousand +24.4%N/A0.5 $0.19
10/31/202274,900 shares $11.98 thousand +21.2%N/A0.4 $0.16
10/15/202261,800 shares $12.66 thousand -65.7%N/A0.3 $0.20
9/30/2022180,000 shares $32.22 thousand -14.6%N/A0.7 $0.18
9/15/2022210,800 shares $51.86 thousand +15.0%N/A0.4 $0.25
8/31/2022183,300 shares $44.80 thousand -1.6%N/A0.3 $0.24
8/15/2022186,200 shares $48.21 thousand +17.7%N/A0.3 $0.26
Iran's New Leader Just Said Something That Should Terrify Every American (Ad)

Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of the world's oil passing through that corridor, crude has already crossed $100 per barrel. History shows gold surged 571% during the 1973 oil crisis and 425% in 1979. Today, the U.S. holds 8,133 tonnes of gold valued on the books at $42.22 per ounce - while gold trades above $5,000. American Alternative Assets has released The Great Gold Reset report detailing what this gap could mean for investors.tc pixel

Claim your free copy of The Great Gold Reset report today
7/31/2022158,200 shares $34.76 thousand +870.6%N/A0.3 $0.22
7/15/202216,300 shares $4.40 thousand -95.0%N/A0 $0.27
6/30/2022325,800 shares $91.22 thousand +15.4%N/A0.4 $0.28
6/15/2022282,400 shares $77.01 thousand -46.6%N/A0.3 $0.27
5/31/2022528,500 shares $160.24 thousand +80.6%N/A0.6 $0.30
5/15/2022292,600 shares $84.85 thousand -19.7%N/A0.2 $0.29
4/30/2022364,500 shares $123.20 thousand -9.5%N/A0.2 $0.34
4/15/2022402,800 shares $157.09 thousand +1,154.8%N/A0.3 $0.39
3/31/202232,100 shares $10.95 thousand -89.0%N/A0 $0.34
3/15/2022291,000 shares $93.12 thousand -46.3%1.6%0.2 $0.32
2/28/2022541,900 shares $211.34 thousand +41.6%3.1%0.4 $0.39
2/15/2022382,700 shares $133.95 thousand -69.9%2.2%0.5 $0.35
1/31/20221,270,000 shares $763.27 thousand +8.6%7.2%1.7 $0.60
1/15/20221,170,000 shares $895.05 thousand +353.7%6.6%1.6 $0.77
12/31/2021257,900 shares $181.15 thousand +8.8%1.5%0.4 $0.70
12/15/2021237,000 shares $218.18 thousand -21.5%1.4%1.1 $0.92
11/30/2021301,800 shares $338.02 thousand +16.1%1.7%1.4 $1.12
11/15/2021260,000 shares $293.80 thousand -19.7%1.5%1.3 $1.13
10/29/2021323,900 shares $446.98 thousand -10.8%1.9%2.2 $1.38
10/15/2021363,200 shares $533.90 thousand -2.6%2.1%2.7 $1.47
9/30/2021373,000 shares $555.77 thousand -16.9%2.2%2.1 $1.49
9/15/2021448,700 shares $695.49 thousand +6.9%2.6%0.9 $1.55
8/31/2021419,600 shares $713.32 thousand 0.0%2.6%0.8 $1.70
8/13/2021419,700 shares $700.90 thousand -3.9%2.6%0.8 $1.67
7/30/2021436,900 shares $751.47 thousand -28.0%2.9%0.9 $1.72
7/15/2021607,000 shares $1.09 million +57.5%4.0%1.2 $1.80
6/30/2021385,400 shares $755.38 thousand +30.4%2.6%0.8 $1.96
6/15/2021295,600 shares $588.24 thousand +1.2%2.0%1.9 $1.99
5/28/2021292,100 shares $540.39 thousand -12.7%1.9%1.3 $1.85
5/14/2021334,400 shares $571.82 thousand +11.1%2.2%1.2 $1.71

CNSP Short Interest - Frequently Asked Questions

Short interest is the volume of CNS Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 38,968 shares of CNSP short. 4.80% of CNS Pharmaceuticals' shares are currently sold short. Learn More on CNS Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CNSP shares currently have a short interest ratio of 2.1. Learn More on CNS Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.80% of CNS Pharmaceuticals' floating shares are currently sold short.

CNS Pharmaceuticals saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 38,968 shares, a decline of 33.2% from the previous total of 58,320 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

4.80% of CNS Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to CNS Pharmaceuticals: Lantern Pharma Inc. (19.49%), VistaGen Therapeutics, Inc. (4.57%), TherapeuticsMD, Inc. (0.50%), Akanda Corp. (66.60%), VYNE Therapeutics Inc. (0.37%), Novogen Limited (24.95%), Pasithea Therapeutics Corp. (1.09%), Exicure, Inc. (1.74%), Cadrenal Therapeutics, Inc. (2.56%), NLS Pharmaceutics Ltd. (1.24%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling CNSP is an investing strategy that aims to generate trading profit from CNS Pharmaceuticals as its price is falling. CNSP shares are trading down $0.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for CNS Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CNSP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNSP, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like CNSP:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:CNSP) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
The US sanctioned itself out of world reserve status…
Russia and Iran are both bypassing the US petrodollar - settling oil trades in alternative currencies while ce...
Golden Portfolio | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Secret behind near perfectly timed stock trades…?
After 20 years of professional trading, Ross Givens says this is the single most lucrative market strategy he ...
Traders Agency | Sponsoredtc pixel
Is this AI lab Elon’s SpaceX lifeline?
Elon Musk went from calling one AI lab 'evil' to striking a deal giving it access to SpaceX's entire Colossus ...
Chaikin Analytics | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel